All In Biotech

Drug Trial Radar · NCT05252117

Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.

Blocking the Uterovaginal Plexus With Artacine for Placement of the Intra Uterine Device

Last checked: Nov 19, 2026Latest source record: Feb 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

240

Planned (sponsor's estimate)

Start

Feb 1, 2021

Primary completion

Apr 30, 2022

Study completion Dec 10, 2022

Sponsor

Lead sponsor
Universidade do Vale do SapucaiAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 23, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 20 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure. Articaine is an amide-linked local anesthetic, its plasma half-life is shorter than that of most other amide-type anesthetics, which makes it theoretically favorable in relation to systemic toxicity.

Conditions

  • Contraception
  • IUD
  • Anesthesia, Local

Interventions

  • Articaine Hydrochloride 40 MG/MLDrug

    Analysis of uterovaginal plexus block with articain for intrauterine device placement

  • MepivacaineDrug

    Analysis of uterovaginal plexus block with mepivacaine for intrauterine device placement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain assessmentTime frame: 15 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Universidade do Vale do Sapucaí

    Pouso Alegre, Minas Gerais, Brazil · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.